Eficácia do ILIB-Modificado sobre os parâmetros clínicos periodontais e controle glicêmico em pacientes com Periodontite portadores de Diabetes Tipo II

Abstract

Periodontitis and type II diabetes are chronic and worldwide high prevalent conditions with a bidirectional relationship between them. Due to this relationship, the proposition of auxiliary therapies for the treatment of periodontitis in diabetic patients, including the low-intensity laser, is a reality. The low-intensity laser is attached to a bracelet over the radial artery to radiate the blood cells through the technique called modified ILIB (Intravascular Laser Irradiation of Blood), aiming the control of the plasma glucose and chronic inflammatory processes. Therefore, this research evaluated the efficacy of the modified ILIB in improving clinical periodontal parameters, such as HbA1c and fasting blood glucose of patients with periodontitis and type II diabetes on a randomized, double-blinded, longitudinal clinical study. The sample included 21 patients distributed in two groups. The control group (CG) received conventional periodontal treatment (scaling and root planning, and oral hygiene guidance), and the test group (TG) received conventional periodontal treatment and 10 laser applications through the modified ILIB technique. The PI and GBI hygiene indexes, the clinical periodontal parameters BoP, PD, CAL, the fasting blood glucose levels and HbA1c were evaluated at the baseline and after 4 months (T4) of treatment for both groups. There were no differences at the intergroup and intragroup comparisons (p>0.05) for the analysis of Hb1AC blood parameters and fasting blood glucose. Concerning to the periodontal parameters, the intragroup analysis showed a significant decay (p<0.05) for the PI, BoP, PD, and CAL indexes between the baseline and T4, however, the intergroup analysis showed no differences between CG and TG (p>0.05) for all the indexes compared. Thus, based on the results is possible to state that the modified ILIB do not improved the glycemic control and the periodontal treatment on type II diabetes patients.